Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 21,476–21,500 of 27,380 studies, newest first · page 860 of 1096.

May 2009 16

  1. 2009-05 month only

    Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings

    ✓ Peer-reviewed Tau biomarkers Archives of neurology

    Key finding: Voxel-based analyses demonstrated significant negative correlations between CSF tau and ptau(181) levels and CMRglu in the posterior cingulate, precuneus, and parahippocampal regions. +4 more findings

  2. 2009-05-01

    Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study

    ✓ Peer-reviewed Treatments Archives of internal medicine

    Key finding: Use of cholinesterase inhibitors is associated with increased rates of syncope, bradycardia, pacemaker insertion, and hip fracture in older adults with dementia. +3 more findings

  3. 2009-05-01

    Amyloid imaging in mild cognitive impairment subtypes

    ✓ Peer-reviewed Brain scans and imaging Annals of neurology

    Key finding: Using cutoffs established from a control cohort, we found that 14 (54%) patients had increased levels of PiB retention and were considered "amyloid-positive." +2 more findings

  4. 2009-05-01

    Management of agitation and aggression associated with Alzheimer disease

    ✓ Peer-reviewed Vascular contributions Nature reviews. Neurology

    Key finding: The most widely prescribed pharmacological treatments for these symptoms-atypical antipsychotics-have a modest but significant beneficial effect in the short-term treatment (over 6-12 weeks) of aggression but limited benefits in longer term therapy.

  5. 2009-05-01

    Phenomenological subtypes of delirium in older persons: patterns, prevalence, and prognosis

    ✓ Peer-reviewed Clinical safety Psychosomatics

    Key finding: The data suggest that instruments measuring delirium severity and psychomotor features provide important prognostic information and should be integrated into the assessment of delirium. +2 more findings

  6. 2009-05-01

    The prevention of dementia

    ✓ Peer-reviewed Prevention trials International journal of geriatric psychiatry

    Key finding: It may be that risk and protective factors vary with age, however, in the absence of prophylactic treatment it seems likely that the maintenance of a healthy lifestyle may represent the best option with regard to the prevention of dementia. +1 more finding

  7. 2009-05-01

    Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier

    ✓ Peer-reviewed Disease mechanisms Journal of immunology (Baltimore, Md. : 1950)

    Key finding: We showed that inhibitors of JNK, ERK, and PI3K significantly decreased Abeta-induced CCR5 expression in human brain microvascular endothelial cells (HBMECs). +3 more findings

  8. 2009-05-01

    The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Journal of neurochemistry

    Key finding: Mitochondria play critical roles in neuronal function and almost all aspects of mitochondrial function are altered in Alzheimer neurons. +3 more findings

  9. 2009-05-01

    Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant

    ✓ Peer-reviewed Brain tissue and pathology Annals of human genetics

    Key finding: The oriental ALDH2*504Lys variant functions as a dominant negative, greatly reducing activity in heterozygotes and abolishing activity in homozygotes. +3 more findings

  10. 2009-05-01

    Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type

    ✓ Peer-reviewed Cognitive tests and assessment Archives of neurology

    Key finding: Cerebrospinal fluid (CSF) levels of Abeta peptide 1-42 (Abeta 42), tau, and phosphorylated tau (ptau) are potential biomarkers of Alzheimer disease. +3 more findings

  11. 2009-05-01

    Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo

    ✓ Peer-reviewed TREM2 and immune genetics Journal of neurochemistry

    Key finding: Markers distinguishing these two populations in tissue sections have not been identified. +3 more findings

  12. 2009-05-01

    The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels

    ✓ Peer-reviewed Risk genes beyond APOE Archives of neurology

    Key finding: Subjects Naive mice, H4 human neuroglioma cells, and H4 human neuroglioma cells stably transfected to express full-length amyloid precursor protein. +3 more findings

  13. 2009-05-01

    2009 Alzheimer's disease facts and figures

    ✓ Peer-reviewed How common it is Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Significant cost implications related to AD and other dementias include an estimated $148 billion annually in direct (Medicare/Medicaid) and indirect (e.g., decreased business productivity) costs.

  14. 2009-05-01

    Age, neuropathology, and dementia

    ✓ Peer-reviewed Caregiving The New England journal of medicine

    Key finding: The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons. +1 more finding

  15. 2009-05-01

    Delirium accelerates cognitive decline in Alzheimer disease

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: Delirium can accelerate the trajectory of cognitive decline in patients with Alzheimer disease (AD). +1 more finding

  16. 2009-05-01

    Association between late-life body mass index and dementia: The Kame Project

    ✓ Peer-reviewed Prevention and risk Neurology

    Key finding: Higher baseline body mass index (BMI) and slower declining BMI in late life are associated with a reduced risk of dementia, suggesting that low BMI or a faster decline in BMI in late life may be preclinical indicators of an underlying dementing illness, especially for those who were initially overweight or obese. +2 more findings

April 2009 9

  1. 2009-04-30

    Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}

    ✓ Peer-reviewed Disease mechanisms The Journal of biological chemistry

    Key finding: Our results suggest that dysfunctions of brain insulin and IGF-1 receptors contribute to Abeta aggregation and subsequent synaptic loss.

  2. 2009-04-29

    The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor

    ✓ Peer-reviewed TREM2 and immune genetics Journal of neurochemistry

    Key finding: Mutations of the receptor (or of its coupling protein, DAP12) sustain in fact a genetic disease affecting the two organs, the polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy (PLOSL or Nasu-Hakola disease). +3 more findings

  3. 2009-04-28

    Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

    ✓ Peer-reviewed Lewy body dementia Acta neuropathologica

    Key finding: The results of the current study, based on examination of a standard set of ten brain regions from 417 subjects stained immunohistochemically for alpha-synuclein, suggest a new staging system that, in this study, allows for the classification of all subjects with Lewy body disorders. +2 more findings

  4. 2009-04-28

    Estrogens, episodic memory, and Alzheimer's disease: a critical update

    ✓ Peer-reviewed Treatments Seminars in reproductive medicine

    Key finding: Partial insight on this critical issue may be gleaned from results of ongoing clinical trials involving midlife postmenopausal women (Early versus Late Intervention Trial with Estrogen; Kronos Early Estrogen Prevention Study).

  5. 2009-04-24

    CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function

    ✓ Peer-reviewed Biomarkers Neurobiology of learning and memory

    Key finding: Activation of astrocytes has been known to be associated with amyloid-beta (Abeta) deposit and production of pro-inflammatory cytokines and chemokines that lead to neuronal cell death in the pathogenesis of Alzheimer disease (AD). +4 more findings

  6. 2009-04-23

    Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models

    ✓ Peer-reviewed Biomarkers International journal of molecular sciences

    Key finding: Although many kinds of peptides are known to be deposited as vascular amyloid, amyloid-beta (Abeta)-CAA is the most common type associated with normal aging, sporadic CAA, Alzheimer's disease (AD) and Down's syndrome. +2 more findings

  7. 2009-04-23

    Test-retest reliability and minimal detectable change scores for the timed "up & go" test, the six-minute walk test, and gait speed in people with Alzheimer disease

    ✓ Peer-reviewed Digital health tools Physical therapy

    Key finding: The TUG, the 6MWT, and gait speed are reliable outcome measures for use with people with AD, recognizing that individual variability of performance is high. +1 more finding

  8. 2009-04-22

    Guiding design of dementia friendly environments in residential care settings: Considering the living experiences

    ✓ Peer-reviewed End-of-life care Dementia

    Key finding: Despite efforts to move aged care away from the medical model to a more balanced social model of care, we still struggle with the dominance of an institutional context which impedes individuality and choice. +4 more findings

  9. 2009-04-22

Browse the library by subject, with the full score breakdown →